News & Updates

The coronavirus disease 2019 (COVID-19) pandemic has disrupted healthcare utilization in the Philippines, leading to lower rates of admission and procedures for certain types of disease, according to a recent study.

Higher intake of alcohol and reduced care during the COVID-19 pandemic have triggered a spike in alcohol-related liver diseases, leading to some serious consequences, according to new research.

Expectant mothers with symptomatic COVID-19 upon hospital admission for delivery had a higher risk of emergency complications surrounding delivery, according to a small retrospective study from the US presented at Anesthesiology 2021. Furthermore, infants born to symptomatic mothers were more likely to require intensive care unit (ICU) admission or respiratory support.

Metabolic dysfunction-associated fatty liver disease (MAFLD) can escalate the incidence of severe COVID-19, but no association between MAFLD and COVID-19 death has been confirmed, suggest the results of a meta-analysis.

Switching to abacavir/lamivudine plus rilpivirine (ABC/3TC + RPV) for maintenance therapy is a safe and effective option for patients with virologically suppressed HIV-1, according to a recent Singapore study.

The neutrophil-to-lymphocyte ratio (NLR) appears to have stronger prognostic value for the coronavirus disease 2019 (COVID-19) than for influenza and the respiratory syncytial virus (RSV), a recent study has found.

Interleukin (IL-6) receptor antagonists provide significant clinical benefit in coronavirus disease 2019 (COVID-19) patients with high baseline mortality risk, a recent study has found. In contrast, such agents pose considerable threat when baseline mortality risk is low.